TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
1. Identity of the issuer or the underlying issuer | Innovaderma PLC | ||||
2 Reason for the notification(please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | X | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to the | Antonios Camille Zamar | ||||
4. Full name of shareholder(s) | JIM Nominees Limited 78 Mount Ephraim, Tunbridge Wells, Kent, TN4 8BS | ||||
5. Date of the transaction and date on | 8 May 2017 | ||||
6. Date on which issuer notified: | 10 May 2017 | ||||
7. Threshold(s) that is/are crossed or | From below 3% to above 3% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to sharesviii, ix | ||||||||||||||||
Class/type of
|
Situation previous | Resulting situation after the triggering transaction | ||||||||||||||
Number |
Number |
Number |
Number of voting | % of voting rights x | ||||||||||||
Direct | Directxi | Indirectxii | Direct | Indirect | ||||||||||||
Ordinary Shares of €0.1 each | 399,082 | 399,082 | 3.185% | |||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instrumentsxv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial | Exercise price | Expiration datexvii |
Exercise/ | Number of voting rights instrument refers to | % of voting rightsxix, xx | |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
399,082 | 3.185% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease | ||
12. Date on which proxy holder will cease to hold | ||
| ||
14. Contact name: | Stephen Nelson at McCarthy Denning | |
15. Contact telephone number: | 07970 546662 | |
This information is provided by RNS
Innovaderma plc published this content on 10 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 May 2017 07:59:10 UTC.
Public permalinkhttp://www.publicnow.com/view/DB7710E68B6D55527B0E9995FD16E5FEFA000B44